Business ❯ Finance ❯ Securities

Investments

Investor Relations Class Action Lawsuits Corporate Governance Investor Compensation Investor Losses Public Companies Pharmaceuticals Stock Market Fraudulent Practices Biopharmaceuticals Public Offerings Investor Protection Market Analysis Class Actions Shareholder Rights Legal Issues Shareholder Actions Class Action Class Action Lawsuit Class Action Litigation Shareholder Claims Real Estate

Firefly Aerospace Investors Face Jan. 12 Deadline to Seek Lead Role in Securities Class Action

These are routine investor solicitations by plaintiff firms rather than court findings.

Bitdeer Investors Face Feb. 2 Deadline to Seek Lead Role in SDNY Securities Class Action

CarMax Securities Suit Enters Lead-Plaintiff Phase as Jan. 2 Deadline Nears

Blue Owl Investors Face Feb. 2 Deadline in Securities Class Action Over BDC Redemption Disclosures

Law Firms Urge Telix Investors To Seek Lead Role by Jan. 9 in Securities Class Action

Telix Class Action Seeks Losses After SEC Subpoena and FDA CRL Disclosures

Blue Owl Capital Hit With Investor Class Action Alleging Hidden Liquidity Strain From BDC Redemptions

Sprouts Farmers Market Faces Securities Class Action With Jan. 26 Lead-Plaintiff Deadline

StubHub Hit With IPO Disclosure Suit as Lead-Plaintiff Race Intensifies

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

Investor Firms Press Sprouts Class Action as Lead‑Plaintiff Deadline Nears

Freeport-McMoRan Investors Urged to Seek Lead Role in Grasberg Safety Class Action

Skye Bioscience Hit With Securities Class Action Over Nimacimab Disclosures as Firms Court Lead Plaintiff

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action

Telix Securities Class Action Draws Flurry of Investor Notices Ahead of Lead-Plaintiff Deadline

CarMax Securities Litigation Intensifies With Expanded Class Period and Jan. 2 Lead-Plaintiff Deadline

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

Telix Sued by Investors Over Prostate Therapy Claims After SEC Subpoena and FDA Rejection

Marex Faces Securities Class Action as Firms Urge Investors to Seek Lead Plaintiff by Dec. 8